In silico identification of targets for a novel scaffold, 2-thiazolylimino-5-benzylidin-thiazolidin-4-one

Thiazolidinone derivatives have been found to exhibit a wide range of pharmacological activities. 2-Thiazolylimino-5-benzylidene-thiazolidin-4-one derivatives show antibacterial activity in in vitro tests which are comparable to marketed drugs. However, the target for this scaffold remains yet to be identified. In our work, we identified seven putative targets for this scaffold using web servers such as DRAR-CPI, PharmMapper, and TarFisDock and databases such as BindingDB and ChEMBL. Each of these servers used different algorithms and scoring functions for protein target identification. Further, these targets are substantiated by molecular docking analysis. Based on the docking studies, scaffold 2-thiazolylimino-5-benzylidene-thiazolidin-4-one is observed to exhibit affinity against diverse targets, particularly, towards COX-2, acetylcholinesterase, aldose reductase, and thyroid hormone receptor alpha. This study describes an initial probability that these proteins may be targeted by this scaffold.

[1]  Kai Huang,et al.  PharmMapper server: a web server for potential drug target identification using pharmacophore mapping approach , 2010, Nucleic Acids Res..

[2]  T. Keller,et al.  A practical view of 'druggability'. , 2006, Current opinion in chemical biology.

[3]  Vladimir V Poroikov,et al.  Computer-aided discovery of anti-inflammatory thiazolidinones with dual cyclooxygenase/lipoxygenase inhibition. , 2008, Journal of medicinal chemistry.

[4]  A. Bender,et al.  In silico target fishing: Predicting biological targets from chemical structure , 2006 .

[5]  X P Chen,et al.  Target validation: A door to drug discovery. , 2007, Drug discoveries & therapeutics.

[6]  Weiliang Zhu,et al.  New technologies in computer-aided drug design: Toward target identification and new chemical entity discovery , 2006, Drug Discovery Today: Technologies.

[7]  Richard D. Taylor,et al.  Improved protein–ligand docking using GOLD , 2003, Proteins.

[8]  V. Poroikov,et al.  Fragment-based design, docking, synthesis, biological evaluation and structure-activity relationships of 2-benzo/benzisothiazolimino-5-aryliden-4-thiazolidinones as cycloxygenase/lipoxygenase inhibitors. , 2012, European journal of medicinal chemistry.

[9]  Hege S. Beard,et al.  Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. , 2004, Journal of medicinal chemistry.

[10]  Masaaki Kotera,et al.  Functional Group and Substructure Searching as a Tool in Metabolomics , 2008, PloS one.

[11]  Mangesh Ghodke,et al.  EXPLORING POTENTIAL OF 4-THIAZOLIDINONE: A BRIEF REVIEW , 2009 .

[12]  Lin He,et al.  DRAR-CPI: a server for identifying drug repositioning potential and adverse drug reactions via the chemical–protein interactome , 2011, Nucleic Acids Res..

[13]  S. Saraf,et al.  4-thiazolidinone--a biologically active scaffold. , 2008, European journal of medicinal chemistry.

[14]  A. Dixit,et al.  2-Thiazolylimino/heteroarylimino-5-arylidene-4-thiazolidinones as new agents with SHP-2 inhibitory action. , 2008, Journal of medicinal chemistry.

[15]  Evan Bolton,et al.  Fast 3D shape screening of large chemical databases through alignment-recycling , 2007, Chemistry Central journal.

[16]  Xiaomin Luo,et al.  PDTD: a web-accessible protein database for drug target identification , 2008, BMC Bioinformatics.

[17]  A. Geronikaki,et al.  Synthesis and antimicrobial activity of novel 2-thiazolylimino-5-arylidene-4-thiazolidinones. , 2006, Bioorganic & medicinal chemistry.

[18]  M. Lindsay.  Target discovery , 2003, Nature Reviews Drug Discovery.

[19]  Rodrigo Lopez,et al.  Clustal W and Clustal X version 2.0 , 2007, Bioinform..

[20]  Xiaomin Luo,et al.  TarFisDock: a web server for identifying drug targets with docking approach , 2006, Nucleic Acids Res..

[21]  Ying Sun,et al.  Design, synthesis, cytoselective toxicity, structure-activity relationships, and pharmacophore of thiazolidinone derivatives targeting drug-resistant lung cancer cells. , 2008, Journal of medicinal chemistry.

[22]  Robert E. Stobaugh.  Chemical substructure searching , 1985, J. Chem. Inf. Comput. Sci..

[23]  V. Srinivasa Rao,et al.  Modern drug discovery process: An in silico approach , 2011 .

[24]  J. Thompson,et al.  The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. , 1997, Nucleic acids research.

[25]  J. Dearden,et al.  2-Heteroarylimino-5-benzylidene-4-thiazolidinones analogues of 2-thiazolylimino-5-benzylidene-4-thiazolidinones with antimicrobial activity: synthesis and structure-activity relationship. , 2008, Bioorganic & medicinal chemistry.

[26]  John P. Overington,et al.  ChEMBL: a large-scale bioactivity database for drug discovery , 2011, Nucleic Acids Res..

[27]  Richard M. Jackson,et al.  Q-SiteFinder: an energy-based method for the prediction of protein-ligand binding sites , 2005, Bioinform..

[28]  Matthew P. Repasky,et al.  Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. , 2004, Journal of medicinal chemistry.

[29]  Vassya Bankova,et al.  Natural products chemistry in the third millennium , 2007, Chemistry Central journal.